Bristol-Myers Squibb Company

BMY · CIK 0000014272

19 fiscal years · 68 SEC filings · every number carries its receipt

Revenue (FY)

$48.19B0.2%

FY2025

Net income (FY)

$7.05B178.8%

FY2025

Free cash flow (FY)

$12.85B7.9%

FY2025

Diluted EPS (FY)

$3.46178.5%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 3.1× since FY2007 · net margin 13.9% → 14.6%

MarginsNet marginFCF margin

FY2025: net 14.6% · free cash flow 26.7% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $14.16B operating cash − $1.31B capex = $12.85B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 43% (FY2008) → 38% (FY2025) · on assets 7.8%

Balance sheetLiabilitiesEquity

FY2025: $90.04B assets · $71.53B liabilities · $18.47B equity

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	48,194	48,300	45,006	46,159	46,385	42,518	26,145	22,561	20,776	19,427	16,560	15,879
Net income	7,054	(8,948)	8,025	6,327	6,994	(9,015)	3,439	4,920	1,007	4,457	1,565	2,004
Diluted EPS	3.46	(4.41)	3.86	2.95	3.12	(3.99)	2.01	3.01	0.61	2.65	0.93	1.20
Diluted shares	2,039	2,027	2,078	2,146	2,245	2,258	1,712	1,637	1,652	1,680	1,679	1,670
Operating cash flow	14,156	15,190	13,860	13,066	16,207	14,052	8,210	7,066	5,275	3,058	2,105	3,148
Capital expenditures	1,311	1,248	1,209	1,118	973	753	836	951	1,055	1,215	820	526
Free cash flow	12,845	13,942	12,651	11,948	15,234	13,299	7,374	6,115	4,220	1,843	1,285	2,622
Cash & equivalents	10,209	10,346	11,464	9,123	13,979	14,546	12,346	6,911	5,421	4,237	2,385	5,571
Total assets	90,038	92,603	95,159	96,820	109,314	118,481	129,944	34,986	33,551	33,707	31,748	33,749
Total liabilities	71,533	76,215	65,674	65,702	73,308	80,599	78,246	20,859	21,704	17,360	17,324	18,766
Shareholders' equity	18,473	16,335	29,430	31,061	35,946	37,822	51,598	14,031	11,741	16,177	14,266	14,852

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. See methodology.